Stockscreener 앱 받기
0.6836
3.72%
-0.0264
전일 마감가:
$0.71
열려 있는:
$0.72
하루 거래량:
159.33K
Relative Volume:
1.63
시가총액:
$42.93M
수익:
$33.79M
순이익/손실:
$-18.67M
주가수익비율:
-1.9084
EPS:
-0.3582
순현금흐름:
$-19.17M
1주 성능:
-6.37%
1개월 성능:
+7.00%
6개월 성능:
-36.11%
1년 성능:
-23.28%
1일 변동 폭
$0.6301
$0.72
1주일 범위
$0.6301
$0.7594
52주 변동 폭
$0.60
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
명칭
Cytosorbents Corp
전화
973-329-8885
주소
305 COLLEGE ROAD EAST, PRINCETON, NJ
CTSO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.6836 | 44.59M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-07 | 개시 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2020-09-17 | 개시 | Jefferies | Buy |
| 2020-09-01 | 개시 | SVB Leerink | Outperform |
| 2017-08-08 | 재확인 | Maxim Group | Buy |
| 2016-10-26 | 개시 | Aegis Capital | Buy |
| 2016-05-24 | 개시 | Maxim Group | Buy |
| 2015-10-29 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 재확인 | MLV & Co | Buy |
| 2015-04-01 | 재확인 | MLV & Co | Buy |
| 2015-03-05 | 개시 | MLV & Co | Buy |
| 2015-02-25 | 개시 | WBB Securities | Speculative Buy |
| 2015-01-27 | 재확인 | H.C. Wainwright | Buy |
모두보기
Cytosorbents Corp 주식(CTSO)의 최신 뉴스
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 - PR Newswire
CytoSorbents (NASDAQ: CTSO) to review $37.0M sales, DrugSorb-ATR in Dec. 15 virtual fireside chat - Stock Titan
Cytosorbents (NASDAQ:CTSO) & BioLife Solutions (NASDAQ:BLFS) Financial Comparison - Defense World
How analysts rate Cytosorbents Corporation stock todayPortfolio Update Summary & Safe Capital Investment Plans - Newser
Can Cytosorbents Corporation (HQE1) stock sustain double digit ROEJuly 2025 Recap & Long-Term Safe Investment Ideas - Newser
What technical patterns form on Cytosorbents Corporation (HQE1) stock chartsVolume Spike & Real-Time Stock Price Movement Reports - Newser
CytoSorbents (CTSO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
How Cytosorbents Corporation stock performs in rising dollar environmentEarnings Performance Report & Verified Short-Term Plans - Newser
Is Cytosorbents Corporation a good long term investmentVolume Profile Analysis & Free Unlock Exclusive Strategies - earlytimes.in
An analyst sees good growth prospects for Cytosorbents Corp (CTSO) - Setenews
CytoSorbents reports Q3 adjusted EPS (4c), consensus (5c) - MSN
CEO Chan Buys 100,000 ($64K) Of CytoSorbents Corp [CTSO] - TradingView
Cytosorbents Corp’s Earnings Call: Growth Amid Challenges - MSN
How Cytosorbents Corporation (HQE1) stock responds to bond marketJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
CTSO CEO Phillip Chan boosts stake with 100,000-share purchase - Stock Titan
Zacks Small Cap Weighs in on Cytosorbents Q1 Earnings - Defense World
Will Cytosorbents Corporation (HQE1) stock remain on Wall Street radarBull Run & Reliable Volume Spike Trade Alerts - newser.com
How buyback programs support Cytosorbents Corporation (HQE1) stockStock Surge & AI Driven Price Predictions - newser.com
CytoSorbents at Jefferies London: Strategic Growth and Regulatory Pathways - Investing.com
Is Cytosorbents Corporation (HQE1) stock a top pick for value investorsBuy Signal & Consistent Return Investment Signals - newser.com
Combining price and volume data for Cytosorbents CorporationJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
Will Cytosorbents Corporation (HQE1) stock benefit from Fed rate cutsForecast Cut & Weekly Consistent Profit Watchlists - newser.com
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London – Company Announcement - Financial Times
Cytosorbents’ (CTSO) Buy Rating Reiterated at D. Boral Capital - Defense World
CytoSorbents (NASDAQ: CTSO) to present at Jefferies Healthcare Conference in London - Stock Titan
HC Wainwright Cuts Cytosorbents (NASDAQ:CTSO) Price Target to $0.75 - Defense World
Published on: 2025-11-16 10:30:06 - newser.com
Using Python tools to backtest Cytosorbents Corporation strategiesMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
CytoSorbents price target lowered to 75c from $1 at H.C. Wainwright - MSN
Will Cytosorbents Corporation stock recover faster than marketMarket Volume Report & Free Community Consensus Stock Picks - newser.com
Will breakout in Cytosorbents Corporation lead to full recoveryGap Up & Free Fast Entry Momentum Trade Alerts - newser.com
CytoSorbents implemented workforce and cost reduction program - MSN
Published on: 2025-11-15 12:38:52 - newser.com
Can machine learning forecast Cytosorbents Corporation recoveryTrade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Cytosorbents Corporation (HQE1.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
CTSO: Analyst Maintains Buy Rating with Steady Price Target of $10.00 | CTSO Stock News - GuruFocus
CytoSorbents Grew Its Sales But Just Missed Profit Targets - Finimize
CTSO Analyst Rating Update: HC Wainwright Lowers Price Target | - GuruFocus
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2025 Earnings Call Transcript - Insider Monkey
CytoSorbents: Q3 Earnings Snapshot - Connecticut Post
CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Recor - GuruFocus
CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
CytoSorbents Reports Strong Q3 2025 Growth and Strategic Advances - TipRanks
Cytosorbents Corp (CTSO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.28%
자본화:
|
볼륨(24시간):